Cargando…

EPH203 Patients Characteristics, Vaccine Uptake, Healthcare Resource Utilization and Costs Associated with Acute COVID-19 during the Omicron Predominant Period in Brazil: A Nationwide Database Study

Detalles Bibliográficos
Autores principales:	Yang, J., Cordeiro, G., Longato, M., Kyaw, M.H., Dantas, A., Senna, T., Ferreira, P., Spinardi, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256461/ http://dx.doi.org/10.1016/j.jval.2023.03.1084

Ejemplares similares

EPH257 Public Health Impact of UK COVID-19 Booster Vaccination during Omicron Predominance
por: Mendes, D., et al.
Publicado: (2023)

EPH203 Estimating the Impact of COVID-19 Pandemic on Gynaecology Treatment in England
por: Sloan, R, et al.
Publicado: (2022)

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period
por: Shoji, Kensuke, et al.
Publicado: (2022)

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
por: Yang, Su Lan, et al.
Publicado: (2022)

The Epidemiological Analysis of COVID-19 Outbreaks in Nursing Homes during the Period of Omicron Variant Predominance
por: Tsai, Jeffrey Che-Hung, et al.
Publicado: (2023)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study
por: Nittayasoot, Natthaprang, et al.
Publicado: (2022)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

EPH205 A Global Analysis of COVID-19 Infection Fatality Rate and Its Associated Factors during the Delta and Omicron Variant Periods
por: Thi Hong, Nhi N
Publicado: (2023)

Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance
por: Sirison, Kanchanok, et al.
Publicado: (2023)

Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022
por: Greene, Sharon K., et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods
por: Stupica, Daša, et al.
Publicado: (2023)

2294. Severity and characteristics of patients hospitalized during Delta and Omicron-predominant COVID-19 time periods in Los Angeles County
por: Greene, Carmon, et al.
Publicado: (2023)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
por: Florentino, Pilar T. V., et al.
Publicado: (2022)

COVID-19 rebound after Paxlovid treatment during Omicron BA.5 vs BA.2.12.1 subvariant predominance period
por: Wang, Lindsey, et al.
Publicado: (2022)

Reduction in severity and mortality in COVID-19 patients owing to heterologous third and fourth-dose vaccines during the periods of delta and omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
por: Montes-González, José Antonio, et al.
Publicado: (2023)

Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea
por: Lee, Jin, et al.
Publicado: (2023)

Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021–March 2022
por: Wilson, W. Wyatt, et al.
Publicado: (2023)

Incidence and outcome of SARS-CoV-2 reinfection in the pre-Omicron era: A global systematic review and meta-analysis
por: Ismail, Nabihah Farhana, et al.
Publicado: (2023)

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue
por: Schiffer, Lina, et al.
Publicado: (2019)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand
por: Intawong, Kannikar, et al.
Publicado: (2023)

Schedule of experiment R203
por: Jarlskog, G
Publicado: (1973)

Quadrupole moment of $^{203}$Fr
por: Wilkins, S G, et al.
Publicado: (2017)

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2022)

EPH252 Contributions and Challenges of Pharmacists during a Public Health Crisis Such As COVID-19
por: Barseghyan, A., et al.
Publicado: (2023)

Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation
por: Giorgio, Carmine, et al.
Publicado: (2011)

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States
por: Schrag, Stephanie J., et al.
Publicado: (2022)

Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study
por: Wan, Jiayue, et al.
Publicado: (2023)

Immunity Acquired From the First Wave of COVID-19 Against Reinfections Up to Omicron Predominance
por: Lan, Fan-Yun, et al.
Publicado: (2023)

Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance
por: Abuhasira, Ran, et al.
Publicado: (2023)

Eph receptors as oncotargets
por: Charmsaz, Sara, et al.
Publicado: (2017)

Eph Receptors in Cancer
por: Arora, Sakshi, et al.
Publicado: (2023)

Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors
por: Janes, Peter W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fhrsq8s6p0km2i4bu6d3869enq